$-0.40 EPS Expected for Pulmatrix (PULM); Shorts at FUTURELAND CORPORATION (FUTL) Raised By 577.5%

October 27, 2017 - By Henry Gaston

Analysts expect Pulmatrix Inc (NASDAQ:PULM) to report $-0.40 EPS on November, 3.They anticipate $0.19 EPS change or 90.48% from last quarter’s $-0.21 EPS. After having $-0.29 EPS previously, Pulmatrix Inc’s analysts see 37.93% EPS growth. It is down 15.00% since October 27, 2016 and is uptrending. It has underperformed by 1.70% the S&P500.

FUTURELAND CORPORATION (OTCMKTS:FUTL) had an increase of 577.5% in short interest. FUTL’s SI was 135,500 shares in October as released by FINRA. Its up 577.5% from 20,000 shares previously. It is 0.00% or $0 reaching $0.0006 per share. It is down 0.00% since October 27, 2016 and is . It has underperformed by 16.70% the S&P500.

Pulmatrix, Inc. is a clinical stage biopharmaceutical firm developing inhaled therapies to address serious pulmonary disease. The company has market cap of $34.52 million. The Company’s product pipeline is focused on advancing treatments for rare diseases, including PUR1900, an inhaled anti-fungal for patients with lung disease, including cystic fibrosis. It currently has negative earnings.

FutureLand, Corp., formerly known as AEGEA, Inc., operates its business through its subsidiary, FutureLand Properties LLC. The company has market cap of $349,430. FutureLand Properties LLC is an agricultural land lease firm catering to the industrial hemp, legal medical marijuana and recreational cannabis market. It currently has negative earnings. The Firm focuses on approximately 240 acres of prime property in southern Colorado.